For help on how to get the results you want, see our search tips.
82 results
Medicine type
Generic Remove Generic filter
Orphan medicine Remove Orphan medicine filter
Accelerated assessment Remove Accelerated assessment filter
Conditional approval Remove Conditional approval filter
Medicine
Summaries of opinion Remove Summaries of opinion filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Summary of opinion: Zynlonta (updated)
loncastuximab tesirine, opinion date: 15/09/2022, Positive, Last updated: 19/09/2022 -
List item
Summary of opinion: Retsevmo
selpercatinib, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Crysvita
burosumab, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022 -
List item
Summary of opinion: Tecartus
Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Retsevmo
selpercatinib, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Teriflunomide Accord (new)
teriflunomide, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Sorafenib Accord (new)
sorafenib, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Pyrukynd (new)
mitapivat, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Yescarta (new)
axicabtagene ciloleucel, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Enjaymo (new)
sutimlimab, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Teriflunomide Mylan (new)
teriflunomide, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Imcivree
setmelanotide, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Withdrawn application: Imcivree (updated)
setmelanotide, date of withdrawal: 22/04/2022, Post-authorisation, Last updated: 28/09/2022 -
List item
Withdrawn application: Livmarli
maralixibat, date of withdrawal: 23/08/2021, Initial authorisation, Last updated: 17/12/2021 -
List item
Withdrawn application: Flynpovi
eflornithine, sulindac, date of withdrawal: 12/10/2021, Initial authorisation, Last updated: 07/12/2021 -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Puldysa
idebenone, date of withdrawal: 28/10/2020, Initial authorisation, Last updated: 18/01/2021 -
List item
Withdrawn application: Upkanz
deferiprone, date of withdrawal: 10/08/2020, Initial authorisation, Last updated: 28/10/2020 -
List item
Withdrawn application: Doxorubicin Hydrochloride Tillomed
doxorubicin, date of withdrawal: 02/03/2020, Initial authorisation, Last updated: 27/07/2020 -
List item
Withdrawn application: Fingolimod Mylan
fingolimod, date of withdrawal: 08/05/2020, Initial authorisation, Last updated: 17/06/2020 -
List item
Withdrawn application: Vynpenta (previously AvacopanChemoCentryx)
date of withdrawal: 23/01/2019, Initial authorisation, Last updated: 15/05/2020 -
List item
Withdrawn application: Opsumit
macitentan, date of withdrawal: 08/11/2019, Post-authorisation, Last updated: 17/02/2020 -
List item
Withdrawn application: Xyndari
date of withdrawal: 18/09/2019, Initial authorisation, Last updated: 11/02/2020 -
List item
Withdrawn application: Radicava
date of withdrawal: 24/05/2019, Initial authorisation, Last updated: 14/08/2019 -
List item
Withdrawn application: Graspa
asparaginase, date of withdrawal: 22/06/2018, Initial authorisation, Last updated: 23/01/2019